Harmful Side Effects: How drug companies undermine global health
Overview
New Oxfam research shows that four pharmaceutical companies – Abbott, Johnson & Johnson, Merck and Pfizer – systematically hide their profits in overseas tax havens. They appear to deprive developing countries of more than $100m (around £80m) every year – money that is urgently needed to meet the health needs of people in these countries – while charging very high prices for their products. In the UK, these four companies may be underpaying around £125m of tax each year. These corporations also deploy massive lobbying operations to influence trade, tax and health policies in their favour and give their damaging behavior greater apparent legitimacy. Tax dodging, high prices and political influencing by pharmaceutical companies exacerbate the yawning gap between rich and poor, between men and women, and between advanced economies and developing ones.
Additional details
Author(s)
How to cite this resource
Citation styles vary so we recommend you check what is appropriate for your context. You may choose to cite Oxfam resources as follows:
Author(s)/Editor(s). (Year of publication). Title and sub-title. Place of publication: name of publisher. DOI (where available). URL
Our FAQs page has some examples of this approach.
The Commitment to Reducing Inequality Index 2024
